Education
About Us
Working with TipRanks
Follow Us
Goodrx Holdings, Inc. (GDRX)
:GDRX
GDRX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.31 - $8.57
Previous CloseN/A
Volume261.88K
Average Volume (3M)4.32M
Market Cap
$1.50B
Enterprise Value$2.04B
Total Cash (Recent Filing)$281.32M
Total Debt (Recent Filing)$547.54M
Price to Earnings (P/E)46.7
Beta0.88
Next Earnings
Nov 06, 2025EPS Estimate
0.09Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.09
Shares Outstanding98,580,670
10 Day Avg. Volume9,784,335
30 Day Avg. Volume4,321,465
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.36
Enterprise Value/Revenue2.56
Enterprise Value/Gross Profit2.80
Enterprise Value/Ebitda11.48
Forecast
1Y Price Target
$5.36Price Target Upside23.79% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering14
Bulls Say, Bears Say
Bulls Say
PartnershipsGoodRx's agreement with Novo Nordisk to offer Ozempic and Wegovy at a discounted cash price is a significant win for the manufacturer solutions segment.
Platform GrowthThe GDRX platform, with over 5.5 million monthly active consumers and connectivity with over 70,000 retail pharmacies across the US, has the scale to be a more significant direct-to-consumer biopharma advertising channel.
Revenue GrowthManufacturing Solutions revenue was a bright spot, increasing 32%, highlighting growing interest from pharma partners.
Bears Say
Evolving Pharmacy LandscapeGoodRx’s weak 2Q results relative to consensus and guidance reduction reflect the challenges the business is facing from the evolving pharmacy landscape.
Pharmacy ClosuresOngoing headwinds from pharmacy closures and reimbursement changes in the pharmacy ecosystem.
Revenue ChallengesGoodrx Holdings, Inc. missed second-quarter estimates and reduced its revenue guidance for 2025.
GoodRx Holdings News
GDRX FAQ
What was Goodrx Holdings, Inc.’s price range in the past 12 months?
Goodrx Holdings, Inc. lowest stock price was $3.31 and its highest was $8.57 in the past 12 months.
What is Goodrx Holdings, Inc.’s market cap?
Goodrx Holdings, Inc.’s market cap is $1.50B.
When is Goodrx Holdings, Inc.’s upcoming earnings report date?
Goodrx Holdings, Inc.’s upcoming earnings report date is Nov 06, 2025 which is in 69 days.
How were Goodrx Holdings, Inc.’s earnings last quarter?
Goodrx Holdings, Inc. released its earnings results on Aug 06, 2025. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.099 by -$0.009.
Is Goodrx Holdings, Inc. overvalued?
According to Wall Street analysts Goodrx Holdings, Inc.’s price is currently Undervalued.
Does Goodrx Holdings, Inc. pay dividends?
Goodrx Holdings, Inc. does not currently pay dividends.
What is Goodrx Holdings, Inc.’s EPS estimate?
Goodrx Holdings, Inc.’s EPS estimate is 0.09.
How many shares outstanding does Goodrx Holdings, Inc. have?
Goodrx Holdings, Inc. has 98,580,670 shares outstanding.
What happened to Goodrx Holdings, Inc.’s price movement after its last earnings report?
Goodrx Holdings, Inc. reported an EPS of $0.09 in its last earnings report, missing expectations of $0.099. Following the earnings report the stock price went down -20.046%.
Which hedge fund is a major shareholder of Goodrx Holdings, Inc.?
Currently, no hedge funds are holding shares in GDRX
GoodRx Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.36 (23.79% Upside)
$5.36 (23.79% Upside)
Blogger Sentiment
Bullish
GDRX Sentiment 70%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 40.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $94.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 28.0%
Last 30 Days ▲ 28.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.61%
12-Months-Change
Fundamentals
Return on Equity
5.27%
Trailing 12-Months
Asset Growth
-10.62%
Trailing 12-Months
Company Description
Goodrx Holdings, Inc.
GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.
GDRX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in the Pharma Manufacturer Solutions segment and improvements in adjusted EBITDA margins. However, significant challenges from the Rite Aid bankruptcy and ISP volume declines negatively impacted revenue. While there are promising initiatives and partnerships underway, the immediate financial outlook faces headwinds.View all GDRX earnings summariesGDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
GDRX Stock 12 Month Forecast
Average Price Target
$5.36
▲(23.79% Upside)
Technical Analysis
Ownership Overview
12.15% Insiders
13.90% Mutual Funds
0.44% Other Institutional Investors
62.60% Public Companies and
Individual Investors